V. Najfeld

V. Najfeld, R. Hoffman, J. Mascarenhas, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.

V. Najfeld, R. Hoffman, G. Barosi, 2014, Blood.

Development of Myelodysplastic Syndrome and Acute Myeloid Leukemia 15 Years after Hydroxyurea Use in a Patient with Sickle Cell Anemia

V. Najfeld, F. Forte, J. Talwar, 2012, Clinical Medicine Insights. Oncology.

Prolonged Low Dose Therapy with a Pan-Deacetylase Inhibtor, Panobinostat (LBH589), in Patients with Myelofibrosis

V. Najfeld, R. Hoffman, J. Goldberg, 2011 .

Evidence for clonal development and stem cell origin of M7 megakaryocytic leukemia.

J. Adamson, V. Najfeld, P. Fialkow, 1988, Leukemia.

Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium.

O. Abdel-Wahab, V. Najfeld, R. Levine, 2012, Leukemia research.

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.

J. Tripodi, V. Najfeld, A. Dueck, 2018, Blood advances.

Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men

F. Ginhoux, M. Merad, V. Najfeld, 2006, The Journal of experimental medicine.

del(2)(p23): a new recurrent abnormality in acute myeloid leukemia.

V. Najfeld, K. Troy, S. Fruchtman, 1990, Cancer genetics and cytogenetics.

Transformation of polycythemia vera to acute nonlymphocytic leukemia accompanied by t(1;3)(p36;q21) karyotype.

V. Najfeld, P. Berk, T. Coyle, 1988, Cancer genetics and cytogenetics.

TdT-positive acute leukemia with monocytoid characteristics. Clinical, cytochemical, cytogenetic and immunologic findings. 24 patients.

V. Najfeld, S. Seremetis, K. Troy, 1984, Haematologica.

TdT-positive acute leukemia with monocytoid characteristics: clinical, cytochemical, cytogenetic, and immunologic findings.

V. Najfeld, S. Seremetis, J. Cuttner, 1984, Blood.

Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma

V. Najfeld, A. Malone, Shanthi Sivendran, 2010, Journal of hematology & oncology.

Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.

J. Tripodi, V. Najfeld, R. Hoffman, 2010, Blood.

Jumping translocations in leukemia.

V. Najfeld, L. Silverman, E. Ambinder, 1995, Leukemia.

Myelodysplastic Syndromes

V. Najfeld, S. E. El Jamal, A. Coltoff, 2021, Atlas of Diagnostic Hematology.

A phase I/II study of vorinostat, an oral histone deacetylase inhibitor, in combination with azacitidine in patients with the myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Initial results of the phase I trial: A New York Cancer Consortium.

J. Licht, V. Najfeld, A. Verma, 2008 .

A Phase II Trial Of Epigenetic Modulators Vorinostat In Combination With Azacitidine (azaC) In Patients With The Myelodysplastic Syndrome (MDS): Initial Results Of Study 6898 Of The New York Cancer Consortium

V. Najfeld, J. Sparano, A. Verma, 2013 .

Trisomy of 1q in preleukaemia with progression to acute leukaemia.

V. Najfeld, P. Fialkow, J. Singer, 2009, Scandinavian journal of haematology.

Agar culture and chromosome analysis of eosinophilic leukaemia.

V. Najfeld, J. Goldman, K. H. Th'ng, 1975, Journal of clinical pathology.

Cytogenetically Normal Acute Myeloid Leukemia with a Novel KIT Mutation in Exon 11 G565V Developing a Sole Trisomy 13 at Relapse: A Clinical Dilemma

V. Najfeld, A. Scalise, M. J. Nieto, 2014, Acta Haematologica.

Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients.

Geetanjali R. Kamath, V. Najfeld, E. Taioli, 2019, Leukemia research.

Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.

Geetanjali R. Kamath, V. Najfeld, E. Taioli, 2019, Carcinogenesis.

CHRONIC LYMPHOCYTIC LEUKÆMIA: CLONAL ORIGIN IN A COMMITTED B-LYMPHOCYTE PROGENITOR

V. Najfeld, P. Fialkow, L. Steinmann, 1978, The Lancet.

Therapeutic options for patients with myelofibrosis in blast phase.

V. Najfeld, R. Hoffman, J. Mascarenhas, 2010, Leukemia research.

Clinical Cancer esearch an Cancer Biology nscriptional Profiling of Polycythemia Vera Identifies Gene ression Patterns Both Dependent and Independent R the Action of JAK 2 V 617 F

Zhang, D. Gilliland, M. Soares, 2010 .

Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup

J. Soulier, A. Baruchel, V. Najfeld, 2003, Leukemia.

Acquisition of the Ph chromosome and BCR-ABL fusion product in AML-M2 and t(8;21) leukemia: cytogenetic and FISH evidence for a late event

V. Najfeld, K. Troy, A. Scalise, 1998, Leukemia.

A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post‐polycythaemia vera/essential thrombocythaemia myelofibrosis (post‐PV/ET MF)

V. Najfeld, R. Hoffman, J. Goldberg, 2013, British journal of haematology.

Precursor Lymphoid Neoplasms

J. Teruya-Feldstein, V. Najfeld, A. Renteria, 2021, Atlas of Diagnostic Hematology.

BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia.

J. Tripodi, V. Najfeld, R. Hoffman, 2013, Blood.

Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia

G. Klein, V. Najfeld, P. Fialkow, 1980, International journal of cancer.

Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells.

P. Elwood, V. Najfeld, A. Antony, 1988, The Journal of clinical investigation.

The gene for human erythrocyte protein 4.2 maps to chromosome 15q15.

D. Ward, V. Najfeld, R. Nagel, 1992, American journal of human genetics.

Identifi cation of a radio-resistant and cycling dermal dendritic cell population in mice and men

F. Ginhoux, M. Merad, V. Najfeld, 2006 .

The Modulating Effect of Azacitidine (Aza C) on the Cytogenetically Tracked MDS Clone Impact Survival.

V. Najfeld, L. Silverman, A. Scalise, 2004 .

Genomic characterization of spleens in patients with myelofibrosis

J. Tripodi, V. Najfeld, R. Hoffman, 2018, Haematologica.

Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia.

A. Gown, J. Singer, V. Najfeld, 1984, Leukemia research.

A murine model for human cord blood transplantation: near-term fetal and neonatal peripheral blood cells can achieve long-term bone marrow engraftment in sublethally irradiated adult recipients.

V. Najfeld, J. Gordon, P. Rubinstein, 1997, Blood.

Myeloid/lymphoid neoplasms with FGFR1 rearrangement

V. Najfeld, H. Kantarjian, G. Garcia-Manero, 2018, Leukemia & lymphoma.

Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis

V. Najfeld, R. Hoffman, G. Barosi, 2012 .

Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera: implications for its role in diagnosis and pathogenesis.

V. Najfeld, Shai Fuchs, K. Lezon-Geyda, 2003, Experimental hematology.

Localization of HTLV-I tax proviral DNA in mononuclear cells.

V. Najfeld, D. Zucker‐Franklin, B. A. Pancake, 2003, Blood cells, molecules & diseases.

Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome.

J. Adamson, V. Najfeld, J. Singer, 1980, Blood.

HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells.

V. Najfeld, V. D’Agati, P. Klotman, 2008, Kidney international.

Translocation (3;21) in Philadelphia chromosome—positive chronic myelogenous leukemia prior to the onset of blast crisis

V. Najfeld, T. Coyle, 1988, American journal of hematology.

Acute Myeloid Leukemia

J. Teruya-Feldstein, V. Najfeld, J. Mascarenhas, 2021, Atlas of Diagnostic Hematology.

Involvement of the B-lymphoid system in chronic myelogenous leukaemia

V. Najfeld, J. Hansen, Paul J. Martin, 1980, Nature.

Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro.

J. Singer, V. Najfeld, Sidney, 1979, Blood.

Allogenic Bone Marrow Transplantation in Severe Gaucher Disease

V. Najfeld, J. Lipton, M. Ludman, 1992, Pediatric Research.

Identification of a proviral structure in human breast cancer.

V. Najfeld, I. Pélisson, Y. Wang, 2001, Cancer research.

Pegylated Interferon Alfa-2a for Polycythemia Vera or Essential Thrombocythemia Resistant or Intolerant to Hydroxyurea.

E. Papaemmanuil, J. Tripodi, V. Najfeld, 2019, Blood.

Adult and fetal human globin genes are expressed following chromosomal transfer into MEL cells.

V. Najfeld, K. Lewison, N. Anagnou, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter.

V. Najfeld, J. Rappoport, M. Lipkowitz, 2001, The Journal of clinical investigation.

Macrocystic (Mammary Analogue) Secretory Carcinoma

V. Najfeld, B. Wenig, F. Petersson, 2019, The American journal of surgical pathology.

Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 Randomized Trial of Pegylated Interferon Alfa-2a (PEG) Versus Hydroxyurea (HU) Therapy for the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET)

A. Mead, J. Tripodi, V. Najfeld, 2018, Blood.

Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21

V. Najfeld, A. Melnick, M. Calasanz, 1999, Leukemia.

A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals

M. Mahajan, E. Schadt, R. Iyengar, 2020, bioRxiv.

Double minute amplification of mutant PDGF receptor α in a mouse glioma model

J. Tripodi, V. Najfeld, Philippe Soriano, 2015, Scientific Reports.

Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia

V. Najfeld, K. Lezon-Geyda, V Najfeld, 2001, Leukemia.

Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplification

J. Tripodi, V. Najfeld, M. Hanna, 2015, SpringerPlus.

Evidence for the embryonic origin of partial chromosome 7 deletion in monozygotic twins with juvenile chronic myelogenous leukemia

V. Najfeld, S. Fruchtman, R. Parker, 1997, Leukemia.

High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.

V. Najfeld, J. Kehrl, C. Theodossiou, 1993, Leukemia.

Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia.

V. Najfeld, P. Fialkow, A. Ferraris, 1993, Leukemia.

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis.

V. Najfeld, R. Levine, N. Zhang, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia.

J. Adamson, I. Bernstein, V. Najfeld, 1987, The New England journal of medicine.

Clonal origin of leukemia – revisited. A tribute to Philip J Fialkow, MD

V. Najfeld, 1998, Leukemia.

del(5q) in acute lymphoblastic leukemia with biphenotypic and early progenitor phenotype.

V. Najfeld, L. Silverman, K. Troy, 1992, Cancer genetics and cytogenetics.

Identification of subpopulations of human macrophages through the generation of human macrophage hybridomas.

V. Najfeld, L. Mayer, J. Bauer, 1990, Journal of immunological methods.

Evidence for clonal development of childhood acute lymphoblastic leukemia.

V. Najfeld, P. Fialkow, P. Martin, 1985, Blood.

Reappraising hyalinizing clear cell carcinoma: A population‐based study with molecular confirmation

C. Cordon-Cardo, J. Tripodi, V. Najfeld, 2017, Head & neck.

Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer

V. Najfeld, W. Raskind, L. Steinmann, 1998, Leukemia.

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

J. Tripodi, V. Najfeld, R. Hoffman, 2022, JCI insight.

Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean?

V. Najfeld, B. Alter, A. Scalise, 1993, British journal of haematology.

Disparate lympho‐erythroid donor to recipient chimaerism in a β°‐thalassaemia bone marrow transplant recipient with red cell indices indicative of apparent full engraftment

V. Najfeld, R. Weinberg, J. Lipton, 1997, British journal of haematology.

An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia

V. Najfeld, L. Isola, S. Richard, 2000, Bone Marrow Transplantation.

Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes

V. Najfeld, E. Scigliano, S. Fruchtman, 1997, Bone Marrow Transplantation.

A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF

V. Najfeld, B. Shank, D. Skerrett, 1997, Bone Marrow Transplantation.

Glutamic Pyruvate Transaminase Phenotypes in Polycythaemia Rubra Vera

V. Najfeld, S. Lawler, S. Welch, 1980, British journal of haematology.

TRANSPLANTATION AND CELLULAR ENGINEERING: Long‐term storage does not alter functionality of in vitro generated human erythroblasts: implications for ex vivo generated erythroid transfusion products

V. Najfeld, A. Migliaccio, G. Migliaccio, 2009, Transfusion.

Collection of autologous PBSC in patients with polycythemia vera.

V. Najfeld, L. Isola, S. Fruchtman, 2003, Cytotherapy.

An unusual case of donor‐derived myelodysplastic syndrome following double‐unit umbilical cord blood transplantation in acute lymphoblastic leukemia

V. Najfeld, J. Mascarenhas, L. Isola, 2012, American journal of hematology.

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase.

V. Najfeld, R. Levine, M. Salama, 2020, Blood advances.

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.

V. Najfeld, R. Levine, M. Salama, 2018, Blood advances.

Duplication and triplication of der(21)t(8;21)(q22;q22) in acute myeloid leukemia.

V. Najfeld, A. Leblanc, D. Manwani, 2009, Cancer genetics and cytogenetics.

The value of interphase fluorescence in situ hybridization in the study of patients with lymphoproliferative disorders: further evidence for a higher sensitivity of detecting chromosomes 7 and 8 aneuploidy.

V. Najfeld, A. Scalise, C. Lempert, 1998, Cancer genetics and cytogenetics.

Fluorescence In Situ Hybridization (FISH) and Conventional Cytogenetics for Hematology and Oncology Diagnosis

V. Najfeld, 2008 .

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

A. Mead, J. Tripodi, V. Najfeld, 2022, Blood.

Differences in the frequency of normal and clonal precursors of colony- forming cells in chronic myelogenous leukemia and acute myelogenous leukemia

I. Bernstein, V. Najfeld, J. Singer, 1992 .

P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemia.

V. Najfeld, O. Witte, E. Kawasaki, 1989, Leukemia.

Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia *

J. Tripodi, V. Najfeld, R. Hoffman, 2010, British journal of haematology.

Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro

J. Singer, V. Najfeld, P. Fialkow, 1979 .

"Masked" Ph1 chromosome in a complex three-way translocation.

V. Najfeld, P. Fialkow, R. Tobe, 1983, Cancer genetics and cytogenetics.

A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.

S. Jagannath, V. Najfeld, J. Mascarenhas, 2013, Clinical lymphoma, myeloma & leukemia.

A Phase I Trial of the Epigenetic Modulators Vorinostat, in Combination with Azacitidine (azaC) in Patients with the Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML): A Study of the New York Cancer Consortium

J. Gabrilove, V. Najfeld, A. Verma, 2008 .

BCR-ABL transcripts may be detected in essential thrombocythemia but lack clinical significance.

V. Najfeld, F. Molinas, P. Heller, 2001, Blood.

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

J. Tripodi, V. Najfeld, M. Arcasoy, 2019, Leukemia.

Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms

V. Najfeld, R. Hoffman, J. Mascarenhas, 2020, Acta Haematologica.

Chronic myelogenous leukemia: Prolonged survival with spontaneous decline in the frequency of Ph1‐positive cells and subsequent development of mixed Ph1‐positive and Ph1‐negative blast crisis

V. Najfeld, F. Appelbaum, J. Singer, 1983, Cancer.

Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression.

J. Tripodi, V. Najfeld, R. Hoffman, 2011, Cancer genetics.

Phase I dose escalation study of lestaurtinib in patients with myelofibrosis

V. Najfeld, R. Hoffman, H. Pahl, 2015, Leukemia & lymphoma.

A new variant translocation 11;17 in a patient with acute promyelocytic leukemia together with t(7;12).

V. Najfeld, K. Troy, A. Scalise, 1989, Cancer genetics and cytogenetics.

B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease.

V. Najfeld, P. Fialkow, P. Martin, 1982, Cancer genetics and cytogenetics.

Chronic myelogenous leukemia occurring in two brothers diagnosed 26 years apart.

V. Najfeld, A. Novoselac, G. Hellman, 2005, Cancer genetics and cytogenetics.

committed stem cells in vitro Chronic myelocytic leukemia (CML): failure to detect residual normal

J. Singer, V. Najfeld, P. Fialkow, 2011 .

A chromosome 11-linked determinant controls fetal globin expression and the fetal-to-adult globin switch.

G. Stamatoyannopoulos, V. Najfeld, T. Papayannopoulou, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Myelofibrosis with complex chromosome abnormality in a patient with erythrocytosis due to hemoglobin rainier and treated with 32P

J. Adamson, V. Najfeld, T. Price, 1978, American journal of hematology.

A Phase I Study of LBH589, a Novel Histone Deacetylase Inhibitor in Patients with Primary Myelofibrosis (PMF) and Post-Polycythemia/Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF).

V. Najfeld, R. Hoffman, J. Goldberg, 2009 .

Myeloproliferative Neoplasms

J. Teruya-Feldstein, V. Najfeld, M. Kremyanskaya, 2021, Atlas of Diagnostic Hematology.

Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells.

J. Tripodi, V. Najfeld, R. Hoffman, 2012, Blood.

Genomic organization and chromosomal localization of the human histone deacetylase 3 gene.

V. Najfeld, S. Emiliani, E. Verdin, 1999, Genomics.

DUPLICATION q21 TO q26 OF CHROMOSOME 3 IN A PATIENT WITH ACUTE MYELOGENOUS LEUKAEMIA‐M1

V. Najfeld, N. Wisch, C. Theodossiou, 1992, British journal of haematology.

Myelodysplastic syndrome transforming to acute promyelocytic‐like leukemia with trisomy and rearrangement of chromosome II

V. Najfeld, S. Waxman, E. Ambinder, 1994 .

Isochromosome 17 in a case of chronic erythroleukaemia.

V. Najfeld, 2009, Scandinavian journal of haematology.

A Multicenter, Open Label Phase I/II Study of CEP701 (Lestaurtinib) in Adults with Myelofibrosis; a Report On Phase I: A Study of the Myeloproliferative Disorders Research Consortium (MPD-RC).

J. Tripodi, V. Najfeld, M. Carroll, 2009 .

Multiploid Inheritance of HIV-1 during Cell-to-Cell Infection

Dominik Wodarz, D. Wodarz, J. Tripodi, 2011, Journal of Virology.

High performance of the BCR/ABL-extra sensitive (ES) probe for detection of der(9q) deletion in t(9;22) (q34;q11.2).

V. Najfeld, 2002, Cancer genetics and cytogenetics.

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

V. Najfeld, 2010, Cancer Genetics and Cytogenetics.

Confirming evidence for the clonal development and stem cell origin of philadelphia chromosome‐negative chronic myelogenous leukemia

F. Kaye, V. Najfeld, P. Fialkow, 1984, American journal of hematology.

Acute myeloid leukemia with an MN1-ETV6 fusion in a young child with Down syndrome

V. Najfeld, N. Shukla, R. Benayed, 2022, Cold Spring Harbor molecular case studies.

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

V. Najfeld, M. Salama, A. Dueck, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Localization of PURA, the gene encoding the sequence-specific single-stranded-DNA-binding protein Pur alpha, to chromosome band 5q31.

D. Ward, V. Najfeld, E. Johnson, 1995, Cytogenetics and cell genetics.

Dose-Adjusted Intensive Chemotherapy Is Safe and Tolerable in Older Patients with Ph-Negative ACUTE Lymphoblastic Leukemia

V. Najfeld, J. Mascarenhas, M. Kremyanskaya, 2018, Biology of Blood and Marrow Transplantation.

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

J. Tripodi, V. Najfeld, A. Dueck, 2019, Blood.

Clinical Cancer esearch an Cancer Biology nscriptional Profiling of Polycythemia Vera Identifies Gene ression Patterns Both Dependent and Independent R the Action of JAK 2 V 617 F

Zhang, D. Gilliland, M. Soares, 2010 .

Clonal development of the acute leukemias.

V. Najfeld, J. Singer, P. Fialkow, 1989, Bone marrow transplantation.

Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12-->p11 by fluorescent in situ hybridization.

V. Najfeld, D. Comings, D. Muhleman, 1993, Cytogenetics and cell genetics.

Characterization Of Splenic Fibroblasts From Patients With Myelofibrosis

J. Tripodi, V. Najfeld, R. Hoffman, 2013 .

Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.

J. Tripodi, V. Najfeld, R. Hoffman, 2010, Blood.

Acquired trisomy 12 and absent Y chromosome in a patients with acute undifferentiated leukaemia.

V. Najfeld, P. Fialkow, D. Thorning, 2009, Scandinavian journal of haematology.

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.

V. Najfeld, M. Salama, A. Dueck, 2018, Blood advances.

Impact of high molecular risk mutations on transplant outcomes in patients with myelofibrosis

V. Najfeld, A. Dueck, C. Famulare, 2019 .

TRANSPLANTATION AND CELLULAR ENGINEERING: Long‐term storage does not alter functionality of in vitro generated human erythroblasts: implications for ex vivo generated erythroid transfusion products

V. Najfeld, A. Migliaccio, G. Migliaccio, 2009, Transfusion.

Fluorescence In Situ Hybridization (FISH) and Conventional Cytogenetics for Hematology and Oncology Diagnosis

V. Najfeld, 2008 .